The DUTCH Test for PCOS: What It Measures and Whether It Changes Treatment
9 min read
A registered dietitian and clinician review is being arranged for this site. Until this article carries a named reviewer, treat it as a well-sourced summary of published guidance — not as a substitute for advice about your own case.
The short answer
The DUTCH test analyzes dried urine strips for sex hormones, their metabolites, and a four-point cortisol curve. It has not been validated against serum testing specifically in PCOS, and the 2023 international PCOS guideline does not recommend it. It does not diagnose PCOS or change guideline-based treatment.
What Does the DUTCH Test Actually Measure?
DUTCH stands for Dried Urine Test for Comprehensive Hormones. A person collects four or five urine samples on filter-paper strips across a single day, mails them to the manufacturer’s lab, and receives a report covering estrogens, progesterone metabolites, androgens including testosterone breakdown products, and a multi-point free cortisol and cortisone curve meant to approximate the day’s cortisol rhythm. The manufacturer states the panel reports dozens of individual hormone metabolites — more than a standard blood panel lists — which is the basis of its “comprehensive” name.
Disclosure: some links on PCOSguides earn an affiliate commission if you buy a product through them. That does not change what follows: nothing in this article recommends buying the DUTCH test, and the evidence below is the same regardless of who sells the kit. Full affiliate disclosure.
Note: in May 2026, PCOS was renamed polyendocrine metabolic ovarian syndrome, or PMOS, by a global consensus of more than 50 organisations. Same condition, same diagnostic criteria — only the label changed, and that includes what counts as evidence for a test like this one. This article uses PCOS, since that is still the term most readers search.
Is the DUTCH Test the Same Thing as a Blood Test?
No — a DUTCH panel and a standard hormone blood panel use different sample types, different laboratory chemistry, and were built to answer different questions. Serum testosterone measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS), or by a well-validated extraction immunoassay, is the method an Endocrine Society position statement recommends for women, specifically because standard direct immunoassays were designed and calibrated around the much higher male range and become unreliable at the low concentrations typical in women. A 2018 review in the European Journal of Endocrinology makes the same point about hyperandrogenism testing generally: the pitfalls are in assay quality and collection timing, not just in which body fluid gets tested. What a standard PCOS blood panel actually orders, and in what sequence, is worth reading before deciding whether an additional urine panel adds anything to it.
| Method | Sample | Guideline-recommended for PCOS? |
|---|---|---|
| Serum testosterone (LC-MS/MS or validated extraction immunoassay) | Blood draw | Yes — the standard the 2023 guideline is built around |
| Dried urine hormone panel (DUTCH) | 4–5 urine spots over one day | No — not mentioned in the guideline’s diagnostic pathway |
| Salivary hormone testing | Multiple saliva samples | No — and the manufacturer’s own published review found it unreliable during hormone therapy monitoring |
Does Any Guideline Recommend the DUTCH Test for PCOS?
No. The current international PCOS guideline directs clinicians to measure free and total testosterone from serum, using a reliable assay method, as part of confirming biochemical hyperandrogenism — one of the three Rotterdam criteria a PCOS diagnosis is actually built from. It does not mention dried urine or saliva testing anywhere in its diagnostic recommendations. Neither does the Endocrine Society’s own position statement on measuring testosterone in women, which exists specifically to steer clinicians away from assay methods that produce unreliable numbers at female-range concentrations. A test that is absent from both documents is not an oversight; it simply has not been evaluated against the standard those guidelines are built on.
Does the Manufacturer’s Own Research Support It?
This is the honest complication: most of the published research that even mentions the DUTCH test’s methodology comes from the company that sells it, Precision Analytical, and its founder is a named author. A 2026 review by that company’s own scientists — examining testosterone monitoring during hormone therapy, not PCOS diagnosis — concluded that serum remains the most accurate, validated method, that saliva testing produces misleadingly high results during transdermal hormone use, and that urine testosterone “may not be as reliable as serum,” especially in people with a common genetic variant (UGT2B17 deletion) that changes how testosterone is excreted in urine. A separate company-run study used the same lab’s own client database — a self-selected group of supplement users, with no independent serum comparison arm — to describe how DUTCH-measured urinary estrogens shift with a supplement, not to validate the panel against blood testing in a PCOS population. Even research funded and authored by the people who sell the test does not claim it outperforms serum for hormone measurement. That is a meaningfully different claim than “comprehensive.”
What About the Argument That Urine Catches More Than a Snapshot?
The case some practitioners make for DUTCH-style testing is that a single blood draw captures one moment, while urine collected across a day reflects total hormone production over that stretch of time. It is a reasonable-sounding argument, and it is not the one the evidence actually settles. A 2019 review of testosterone measurement in Maturitas walks through what actually drives inaccurate results in women: assay choice, collection timing relative to the menstrual cycle, and cross-reactivity with other steroids in cheaper immunoassays — not the sample being a single point in time. A well-timed serum sample, run on a properly validated assay, is a reliable enough snapshot for diagnostic purposes precisely because normal circulating testosterone in women does not swing wildly hour to hour the way cortisol does. The “one moment versus a full picture” framing borrows credibility from cortisol testing, where timing genuinely matters, and applies it to androgens, where the argument does not hold in the same way.
What Might the Cortisol Curve Be Useful For?
The one piece of the panel with a plausible edge over standard bloodwork is the multi-point cortisol and cortisone curve — a single serum cortisol draw only captures one moment, while four or five urine points sketch a rough daily pattern. Some functional-medicine practitioners use that curve to look at diurnal rhythm alongside other findings. Even there, though, this is not a PCOS-specific measurement, it is not part of the Rotterdam criteria, and no trial has shown that acting on a DUTCH cortisol curve changes PCOS outcomes.
Who Is the DUTCH Test Not For?
- Anyone trying to get or confirm a PCOS diagnosis. It is not part of the Rotterdam criteria and does not replace the standard hormone panel or pelvic ultrasound your workup actually needs.
- Anyone expecting results to change a treatment plan. No trial has shown that DUTCH results alter management decisions in PCOS. Guideline-based treatment — metformin, combined hormonal contraception, letrozole for fertility, lifestyle changes — is chosen from clinical findings and standard labs, not urine metabolite ratios.
- Anyone on hormonal contraception, HRT, or any exogenous hormone. Like other hormone tests, these distort results — and the manufacturer’s own published data shows non-serum testing can swing unpredictably during hormone therapy.
- Anyone price-sensitive. This panel is almost always paid out of pocket, and prices change. Check the current price directly with the lab or ordering provider rather than trust a number printed anywhere else, including here.
Should You Ever Get One Anyway?
If a functional-medicine practitioner suggests it as an add-on for exploring symptoms your standard workup has not explained, that is a reasonable thing to discuss with them — but it should sit alongside guideline-based testing, never replace it. Bring any outside results to the clinician managing your Ferriman-Gallwey scoring or hormone bloodwork so they can put the numbers in the context of what your actual diagnostic workup requires, and expect that confirming a PCOS diagnosis properly takes weeks to months regardless of which extra tests get added along the way.
Worth knowing before that conversation: DUTCH results are typically compared against ranges built from the lab’s own client population, not the diagnostic reference ranges your prescribing clinician uses for serum testosterone or DHEA-S. Two practitioners looking at the same DUTCH report can reasonably disagree about what counts as “high” or “low,” because the ranges themselves were never designed to answer a diagnostic question — they describe where a result falls relative to other people who have taken the same test, which is a different thing from a validated clinical cutoff. That distinction is easy to miss on a colourful, detailed-looking report, and it is the main reason a DUTCH result should travel with you to a clinician rather than be acted on alone.
Common Questions
Common questions
Is there a version of DUTCH Complete specifically for PCOS?
No. DUTCH Complete is the same general hormone and cortisol panel regardless of why someone orders it. No clinical trial has evaluated it as a PCOS diagnostic tool, and it is not adapted or validated for that specific use.What is a dried urine hormone test, generally?
It is a method that collects urine on filter-paper strips, dries them, and measures hormone metabolites by mass spectrometry rather than drawing blood. It is used across several commercial labs, not only Precision Analytical, but none of them have guideline backing for PCOS diagnosis.Can the DUTCH test diagnose PCOS?
No. PCOS is diagnosed under the Rotterdam criteria using clinical history, serum hormone testing, and often pelvic ultrasound, after other conditions are ruled out. Urine hormone panels are not part of that pathway in the 2023 international guideline.Is the DUTCH test covered by insurance?
Rarely, in most health systems, because it is not part of a guideline-recommended diagnostic pathway. Check directly with your insurer and the ordering lab, since coverage policies and self-pay prices both change.How much does the DUTCH test cost?
Prices vary by provider and change over time, typically running to several hundred US dollars paid out of pocket. Check the current price directly with the lab or the practitioner ordering it rather than relying on a number from any article, including this one.Is the DUTCH test more accurate than a blood test for hormones?
No independent evidence supports that claim. Even research authored by the test's own manufacturer concludes that serum remains the most accurate, validated method for hormone measurement, with urine testing carrying its own reliability limits.
- Are the 4 Types of PCOS Real? What the Phenotypes Actually AreThe '4 types of PCOS' online aren't a real diagnosis. Here's the actual Rotterdam A-D phenotype system doctors use, and what each label means.
- The Ferriman-Gallwey Score: How Hirsutism Is Actually MeasuredThe Ferriman-Gallwey score rates hair growth at nine body sites on a 0–4 scale. What counts as hirsutism, why ethnicity shifts the cutoff, and its real limits.
- How Long a PCOS Diagnosis Takes — and Why the Average Is Over Two YearsOne-third of women wait over two years for a PCOS diagnosis. Why exclusion-based testing takes so long, what speeds it up, and who it fails most often.
- Is PMOS the Same as PCOS? Yes — Here Is Exactly What ChangedPMOS and PCOS are the same condition. A 2026 global consensus in The Lancet changed the name, not the diagnostic criteria, the biology, or the treatment.
Sources
- 1.Teede HJ, Tay CT, Laven JJE, et al. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023.
- 2.Rosner W, Auchus RJ, Azziz R, et al. Position Statement: Utility, Limitations, and Pitfalls in Measuring Testosterone — An Endocrine Society Position Statement. J Clin Endocrinol Metab. 2007.
- 3.Pugeat M, Plotton I, de la Perrière AB, et al. Hyperandrogenic States in Women: Pitfalls in Laboratory Diagnosis. Eur J Endocrinol. 2018.
- 4.Newman MS, Smeaton J, Gillson G, Jaferi A. Alternatives to Serum Testing for Transdermal Testosterone Monitoring: A Review of Clinical Data and Correlation With Clinical Response. Front Reprod Health. 2026.
- 5.Kanakis GA, Tsametis CP, Goulis DG. Measuring Testosterone in Women and Men. Maturitas. 2019.
- 6.Teede HJ, Khomami MB, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026.